secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHINA PHARMA HOLDINGS, INC. (CPHI)
CIK:        0001106644
Form:       8-K
Filed at:   2026-01-06T23:59:59+00:00
Accession:  0001213900-26-001785
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

China Pharma Holdings shareholders approve reverse stock split up to 1:20 at annual meeting
--------------------------------------------------------------------------------

- Elected independent directors Gene Michael Bennett, Yingwen Zhang, Baowen Dong (3,500,418+ votes for each).
- Approved reverse stock split up to 1:20 (3,500,256 for, 780 against); Board has discretion on timing.
- Approved Amendment No.3 to the Amended and Restated 2010 Long-Term Incentive Plan (3,500,258 for).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1106644/000121390026001785/0001213900-26-001785-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1106644/000121390026001785/ea0271960-8k_chinapharm.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-001785

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer